Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1979-04-02
1980-10-07
Tovar, Jose
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548216, C07D26344, A61K 3142
Patent
active
042268753
ABSTRACT:
Novel spiro-oxazolidinediones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.
REFERENCES:
R. W. Stoughton, J.A.C.S. 63, 2376, (1941).
J. W. Clark-Lewis, Chemical Reviews 58, 63, (1958).
M. A. Spielman, J.A.C.S. 66, 1244, (1944).
H. Najer et al., Bull. Soc. Chim., Fr. 1961, 1226, (1961).
Knuth Charles J.
Murphy Francis X.
Pfizer Inc.
Richardson Peter C.
Tovar Jose
LandOfFree
Novel spiro-oxazolidinediones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel spiro-oxazolidinediones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel spiro-oxazolidinediones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618762